C. García-Vallecillos

Real-world outcomes of COVID-19 treatment with remdesivir in a Spanish hospital

C. Hidalgo-Tenorio, C. García-Vallecillos, Sergio Sequera-Arquelladas, 2021, Medicine.

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial

C. Hidalgo-Tenorio, M. Fariñas, F. Lozano, 2018, PloS one.

Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program

C. Hidalgo-Tenorio, S. Sadyrbaeva-Dolgova, J. Pasquau-Liaño, 2022, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV

C. Hidalgo-Tenorio, J. Pasquau, M. López-Ruz, 2022, Viruses.

DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)

J. Blanco, C. Hidalgo-Tenorio, A. Terrón, 2022, Viruses.

DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain

J. Pasquau, Sergio Ferra-Murcia, C. García-Vallecillos, 2024, Viruses.